COVID-19, flu and RSV shots − an epidemiologist explains why all three matter this fall

The Food and Drug Administration approved and granted emergency use authorization on Aug. 22, 2024, for the newest, updated version of the COVID-19 vaccine. The Centers for Disease Control and…

Vaccines against COVID-19, the seasonal flu and RSV are our best chance of preventing a winter surge

As cold and flu season ramps up, health care experts are once again on high alert for the possibility of a tripledemic, or a surge brought on by the respiratory…

FDA’s greenlighting of maternal RSV vaccine represents a major step forward in protecting young babies against the virus

With the Food and Drug Administration’s Aug. 21, 2023, approval of the first vaccine against respiratory syncytial virus, or RSV, for use during late pregnancy, the U.S. will soon have…